MEA Infusion Therapy Devices Market - Forecast(2024 - 2030)

MEA Infusion Therapy Devices Market size is forecast to reach $560.27 million by 2025, growing at a CAGR of 4.71% during the forecast period 2020-2025. Growing cases of surgical procedures, increasing cases of cancer disease and fruitful treatments by healthcare organizations are the major factors driving the growth of the market. Increasing health awareness and entry of new startups in the MEA Infusion Therapy Industry is poised to further enhance the overall market demand of MEA Infusion Therapy Devices during the forecast period 2020-2025. 

The report: “MEA Infusion Therapy Devices Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the MEA Infusion Therapy Devices market. 

By Infusion Pumps: Large Volume Infusion Pumps, Syringe Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Ambulatory Infusion Pumps, Chemotherapy Infusion Pumps, Disposable Infusion Pumps, Enteral Infusion Pumps, Insulin Infusion Pumps, Implantable Infusion Pumps, Others 

By Infusion Method: Intravenous, Arterial, Subcutaneous, Epidural 

By Infusion Type: Continuous Infusion, Intermittent Infusion, Infusion-on-demand, Total Parenteral Infusion

By Pump Operation Type: Syringe Pump, Elastomeric Pump, Peristaltic Pump, Multi-Channel Pump, Smart Pump

By Accesories and Consumables: I.V. Sets, Docking Stations, Needleless Connectors, Pump Reservoirs/Cartridges, Valves and Filters, Wireless Connectivity, Barcode Readers, Infusion Data Management/Analysis Software, Others

By Application: Chemotherapy, Anti-infective/Antibiotics, Enteral Nutrition, Pain Management, Total Parenteral Nutrition (TPN), Hydration, Others

By End Users: Hospitals, Clinics, Home Healthcare, Ambulatory Surgical Centers, Others

By Geography: Middle East (UAE, Saudi Arabia, Turkey, Israel, Egypt, Rest of Middle East) Africa (South Africa, Rest of Africa)

Large Volume Infusion Pumps segment held the largest share in the MEA Infusion Therapy Devices market in 2019 and is estimated to grow at a CAGR of 3.98% during the forecast period 2020-2025. Large volume pumps can pump fluid replacement such as saline solution, medications such as antibiotics or nutrient solutions large enough to feed a patient. Their efficiency drives the segment growth. Reduced manufacturing costs and growing medical usage are projected to help in the growth during the forecast period 2020-2025. Ambulatory Infusion Pumps held the second largest share in the market, owing to their easier use, safer medication process and alternative care facilities. Ambulatory Infusion Pumps is estimated to be the fastest growing segment and is set to register highest CAGR during the forecast period 2020-2025, owing to effectiveness of recovery costs by improving clinical outcomes and reduced length of hospital stays.

Intravenous segment holds major share in the MEA Infusion Therapy Devices market in 2019. This is owing to the increasing ageing population, rising preference for home care, and rapid technological advancements. Decreased mobility profile is projected to drive the market growth of the segment. Subcutaneous segment is estimated to be the fastest growing segment in the market, owing to more user profile vibes and new startups related.

Continuous Infusion segment holds major share in the MEA Infusion Therapy Devices market in 2019. This is owing to the advantage of maintaining a therapeutic level of diuretic over a more extended period than bolus administration. One clinical advantage of continuous dosing is that it requires less attention compared with repeated bolus dosing on an as-needed basis. Infusion-on-demand is projected to witness steady growth in the forecast period 2020-2025, owing to demand for home centered healthcare facilities.

Hospital segment holds major share in the MEA Infusion Therapy Devices market in 2019. This is owing to the increasing availability of facilities and greater financial capabilities. Availability of trained professionals to operate infusion pumps are projected to drive the market growth of the segment. Ambulatory care settings segment is set to be the fastest growing segment in the market, owing to increase in adoption and demand for minimally invasive surgery, technological advancements.

Saudi Arabia dominated the MEA Infusion Therapy Devices market with a share of more than 31.5%, followed by UAE. Increase in competition and continuous technological advancements in this region have led to enhancements in the product portfolio. Rising state funded policies has boosted the growth of the market in this region. New startups in the market and recent mergers of key players that are in the market are also supporting in the growth of the market.

However, South Africa is estimated to grow at a higher CAGR during the forecast period 2020-2025. This is owing to the rising disposable incomes, launch of new key players and upcoming prevalence of various diseases in these regions.

There is an increase in number of growing surgical cases over the years. With the gradual shift of people’s attention towards a better body, and a healthier lifestyle, the market size of the MEA Infusion Therapy Devices Industry is estimated to increase by a big margin.

 

The purchasing power of various healthcare organizations determines how much products is sold annually. With a surge in economic stock markets, healthcare organizations are gradually strengthening their financial power. Increased purchasing power of the healthcare sector is a driving factor for the growth in the market.

MEA Infusion Therapy Devices Market depends more on the launch of new products, owing to many opportunities being untouched by existing players. This is poised to create challenge to the growth of the MEA Infusion Therapy Devices Market.

Product launches, mergers and acquisitions, joint ventures and R&D activities are key strategies adopted by players in the MEA Infusion therapy devices market. In 2019, MEA Infusion Therapy Devices market share is consolidated by the top players present in the market. MEA Infusion Therapy Devices top companies are 4US Medical, Abraj Al Zahira Investment, Medgte Medical Supplies, Hospira, Excel Trading & Engineering services, Alamary Med, Abet Healthcare, Equimed Group Sarl, B. Braun and Ledertech (Pty) Ltd among others.